Skip to main content
. 2019 Apr 26;6:86. doi: 10.3389/fmed.2019.00086

Figure 3.

Figure 3

Serum levels of CCL22 and the ROC curve in melanoma. The ROC curve was used to calculate cut-offs for CCL22 serum levels and the AUC. Cut-offs were determined to distinguish responders from non-responders using Youden's index (A). Mean serum levels of CCL22 in responders (n = 16) and non-responders (n = 30) at day 0 (B). (n.s, not significant).